Keyphrases
Chronic Lymphocytic Leukemia
100%
Tumor
52%
Magnetic Resonance Elastography
41%
Natural Killer Cells
41%
Acute Myeloid Leukemia
39%
Spinal Cord Injury
38%
Chronic Lymphocytic Leukemia Cells
36%
Monocytes
34%
Glioblastoma
33%
Macrophages
29%
Stiffness
28%
Cytotoxicity
27%
Fc Receptor
24%
Leukemia
24%
Antibody-dependent Cellular Cytotoxicity
23%
Sterol Regulatory Element-binding protein-1c (SREBP-1c)
20%
Lenalidomide
20%
MicroRNA
19%
Histone Deacetylase Inhibitor (HDACi)
19%
MR Elastography
19%
Environmental Enrichment
19%
CD37
19%
Oncolytic Herpes Simplex Virus (oHSV)
18%
Tumor Cells
16%
B Cells
16%
Mouse Model
16%
Overall Survival
16%
Tumor Growth
15%
Receptor Function
15%
Myocardial Stiffness
15%
AR-42
15%
Zoledronic Acid
15%
Interleukin-21 (IL-21)
14%
Phase II Trial
14%
Leukemia Patients
14%
Transcription Factor
14%
Xenograft
14%
Extracellular Vesicles
13%
Antibody Therapy
13%
T Cells
13%
Monoclonal Antibody
13%
Cancer Cells
13%
Gene Therapy
12%
Ewing Sarcoma
12%
Lung
12%
Clinical Trials
12%
Stiffness Estimation
12%
Human Monocytes
12%
Porcine Model
12%
OSU-2S
12%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
69%
Neoplasm
55%
In Vitro
38%
Magnetic Resonance Elastography
38%
Glioblastoma
32%
Cytotoxicity
29%
Spinal Cord Injury
26%
Xenograft
24%
Natural Killer Cell
24%
Receptor
21%
Acute Myeloid Leukemia
20%
Reproducibility
19%
Non Small Cell Lung Cancer
19%
Lung
18%
B Cell
18%
Cell Line
17%
Antibody Dependent Cellular Cytotoxicity
16%
Macrophage
16%
Leukemia
15%
Immunotherapy
15%
Disease
15%
Stereotactic Body Radiation Therapy
15%
Cancer
15%
Primary Tumor
14%
Tumor Cell
14%
Injury
14%
Programmed Cell Death
14%
Leukemia Cell
13%
T Cell
13%
microRNA
13%
Messenger RNA
13%
Lenalidomide
12%
Connective Tissue Cancer
12%
Cancer Cell
11%
Volunteer
11%
Histone Deacetylase Inhibitor
11%
Clinical Trial
11%
Biological Marker
11%
Overall Survival
10%
Immunity
10%
Malignant Neoplasm
10%
Pancreas Cancer
9%
Downregulation
9%
Chemotherapy
8%
Chemoradiotherapy
8%
Monoclonal Antibody
8%
Chimeric Antigen Receptor
8%
Gene Therapy
8%
Ewing Sarcoma
8%
Breast Cancer
8%